Literature DB >> 19043604

Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection.

M Thapa1, D J J Carr.   

Abstract

HSV-2 is a highly successful human pathogen with a remarkable ability to elude immune detection or counter the innate and adaptive immune response through the production of viral-encoded proteins. In response to infection, resident cells secrete soluble factors including chemokines that mobilize and guide leukocytes including T and NK cells, neutrophils, and monocytes to sites of infection. While there is built-in redundancy within the system, chemokines signal through specific membrane-bound receptors that act as antennae detailing a chemical pathway that will provide a means to locate and eliminate the viral insult. Within the central nervous system (CNS), the temporal and spatial expression of chemokines relative to leukocyte mobilization in response to HSV-2 infection has not been elucidated. This paper will review some of the chemokine/chemokine receptor candidates that appear critical to the host in viral resistance and clearance from the CNS and peripheral tissue using murine models of genital HSV-2 infection.

Entities:  

Year:  2008        PMID: 19043604      PMCID: PMC2586324          DOI: 10.2174/1874226200801010033

Source DB:  PubMed          Journal:  Open Immunol J


  118 in total

Review 1.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis.

Authors:  V G Sasseville; M M Smith; C R Mackay; D R Pauley; K G Mansfield; D J Ringler; A A Lackner
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

3.  Production of chemokine CXCL1/KC by okadaic acid through the nuclear factor-kappaB pathway.

Authors:  Gong Feng; Yoshihiro Ohmori; Pi-Ling Chang
Journal:  Carcinogenesis       Date:  2005-07-06       Impact factor: 4.944

4.  Role of polymorphonuclear leukocytes in resolution of HSV-2 infection of the mouse vagina.

Authors:  G N Milligan; N Bourne; K L Dudley
Journal:  J Reprod Immunol       Date:  2001-01       Impact factor: 4.054

5.  Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization.

Authors:  Manoj Thapa; William A Kuziel; Daniel J J Carr
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

6.  Macrophage inflammatory protein-1alpha expression plasmid enhances DNA vaccine-induced immune responses against HSV-2.

Authors:  Wenai Shao; Xiaomian Li; Mei Li; Liying Shi; Yu Qin; Kangsheng Li
Journal:  Immunol Cell Biol       Date:  2005-12       Impact factor: 5.126

7.  CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels.

Authors:  Ulrich A Maus; Sandra Wellmann; Christine Hampl; William A Kuziel; Mrigank Srivastava; Matthias Mack; M Brett Everhart; Timothy S Blackwell; John W Christman; Detlef Schlöndorff; Rainer M Bohle; Werner Seeger; Jürgen Lohmeyer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-10-29       Impact factor: 5.464

8.  Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors.

Authors:  Y Weng; S J Siciliano; K E Waldburger; A Sirotina-Meisher; M J Staruch; B L Daugherty; S L Gould; M S Springer; J A DeMartino
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

9.  NF-kappaB p50 facilitates neutrophil accumulation during LPS-induced pulmonary inflammation.

Authors:  Joseph P Mizgerd; Michal M Lupa; Matt S Spieker
Journal:  BMC Immunol       Date:  2004-06-09       Impact factor: 3.615

10.  Blocking CC chemokine receptor (CCR) 1 and CCR5 during herpes simplex virus type 2 infection in vivo impairs host defence and perturbs the cytokine response.

Authors:  L N Sørensen; S R Paludan
Journal:  Scand J Immunol       Date:  2004-03       Impact factor: 3.487

View more
  15 in total

1.  IL-36γ induces a transient HSV-2 resistant environment that protects against genital disease and pathogenesis.

Authors:  Jameson K Gardner; Melissa M Herbst-Kralovetz
Journal:  Cytokine       Date:  2018-08-15       Impact factor: 3.861

2.  CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8+ TEM and CD8+ TRM Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.

Authors:  Ruchi Srivastava; Arif A Khan; Sravya Chilukuri; Sabrina A Syed; Tien T Tran; Julie Furness; Elmostafa Bahraoui; Lbachir BenMohamed
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

3.  Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection.

Authors:  Christopher D Conrady; William P Halford; Daniel J J Carr
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

4.  Transcriptional Analysis of the Guinea Pig Mucosal Immune Response to Intravaginal Infection with Herpes Simplex Virus Type 2.

Authors:  Ronald L Veselenak; Gregg N Milligan; Aaron L Miller; Richard B Pyles; Nigel Bourne
Journal:  Virology       Date:  2018-03-28       Impact factor: 3.616

5.  CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration.

Authors:  Manoj Thapa; Daniel J J Carr
Journal:  J Virol       Date:  2009-07-08       Impact factor: 5.103

6.  Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes.

Authors:  Anna G Drannik; Kakon Nag; Jean-Michel Sallenave; Kenneth L Rosenthal
Journal:  J Virol       Date:  2013-05-01       Impact factor: 5.103

7.  Stepwise release of biologically active HMGB1 during HSV-2 infection.

Authors:  Chloé Borde; Stéphanie Barnay-Verdier; Claire Gaillard; Hakim Hocini; Vincent Maréchal; Joël Gozlan
Journal:  PLoS One       Date:  2011-01-19       Impact factor: 3.240

8.  Role of Fas/FasL in regulation of inflammation in vaginal tissue during HSV-2 infection.

Authors:  M Krzyzowska; A Shestakov; K Eriksson; F Chiodi
Journal:  Cell Death Dis       Date:  2011-03-17       Impact factor: 8.469

9.  Enhancement of chemokine function as an immunomodulatory strategy employed by human herpesviruses.

Authors:  Abel Viejo-Borbolla; Nadia Martinez-Martín; Hendrik J Nel; Patricia Rueda; Rocío Martín; Soledad Blanco; Fernando Arenzana-Seisdedos; Marcus Thelen; Padraic G Fallon; Antonio Alcamí
Journal:  PLoS Pathog       Date:  2012-02-02       Impact factor: 6.823

10.  HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.

Authors:  Malgorzata Krzyzowska; Piotr Baska; Piotr Orlowski; Robert Zdanowski; Anna Winnicka; Kristina Eriksson; Wanda Stankiewicz
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.